Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting. [electronic resource]
Producer: 20200608Description: 160-169 p. digitalISSN:- 1530-0366
- Aged
- Clopidogrel -- administration & dosage
- Coronary Occlusion -- genetics
- Cytochrome P-450 CYP2C19 -- genetics
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- administration & dosage
- Prasugrel Hydrochloride -- administration & dosage
- Precision Medicine
- Prospective Studies
- Ticlopidine -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.